Document is current
Any future updates will be listed below
-
Authors
Byrne, Hilary L.
Eikelis, Nina
Dusting, Jonathan
Fouras, Andreas
Keall, Paul J.
Pirakalathanan, Piraveen
-
Funding
Funding for this research was provided by:
Cancer Institute NSW Translational Program Grant (2019/TPG2165, 2019/TPG2165)
Australian Government fellowship (REDIF147)
- License Information
-
More Information
Article History
Received: 21 October 2024
Accepted: 18 April 2025
First Online: 26 April 2025
Declarations
:
: This study uses data from a prospective single institution clinical trial approved by the health district ethics committee (HREC/12/169) and registered with the Australian New Zealand Clinical Trials Registry (ACTRN12612000775819, registration date 23/07/2012). The study was approved by the Northern Health Human Research Ethics Committee on 21/03/2013 (Ethics approval number 1206-175 M).
: To Publish is not applicable for this retrospective study.
: NE, JD, AF, PP are employees of 4DMedical Ltd which produces the CT LVAS product.PK is an inventor on a licenced patent on CT ventilation imaging. HB received an Australian Government fellowship (REDIF147) to carry out work presented in this manuscript.
